AI assistant
Sending…
Dechra Pharmaceuticals PLC — Major Shareholding Notification 2013
Jan 11, 2013
4797_mrq_2013-01-11_46f947c2-e312-42f2-81f8-97bb3b097501.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 3965V
Dechra Pharmaceuticals PLC
11 January 2013
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Dechra Pharmaceuticals plc | ||||
| 2 Reason for the notification (please tick the appropriate box or boxes): | |||||
| An acquisition or disposal of voting rights | x | ||||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
| An event changing the breakdown of voting rights | |||||
| Other (please specify): | |||||
| 3. Full name of person(s) subject to the notification obligation: iii |
Invesco Limited | ||||
| 4. Full name of shareholder(s) (if different from 3.):iv | |||||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v |
09 January 2013 | ||||
| 6. Date on which issuer notified: | 11 January 2013 | ||||
| 7. Threshold(s) that is/are crossed or reached: vi, vii |
4%, 5% | ||||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares viii, ix | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x | ||||||||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
| Ordinary 1p Shares | 4,352,940 | 4,352,940 | 4,348,519 | 5.00% | ||||||||||||
| GB0009633180 | ||||||||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Exercise price | Expiration date xvii | Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
| Nominal | Delta | |||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| 4,348,519 | 5.00% | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
||
| Invesco Asset Management Ltd - 939,162 Invesco Fund Managers Ltd - 3,068,384 Invesco Asset Management Dublin Ltd - 274,501 Invesco Asset Management Ltd & Invesco Advisers Inc. - 23,461 Invesco Canada Ltd & Invesco Advisers Inc. - 21,954 Invesco GT Management S.A - 16,190 Invesco Asset Management Japan Ltd - 6,145 Invesco PowerShares Capital Management Limited - 4,610 |
||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | ||
| 11. Number of voting rights proxy holder will cease to hold: |
||
| 12. Date on which proxy holder will cease to hold voting rights: |
||
| 13. Additional information: | ||
| 14. Contact name: | Sam Edwards | |
| 15. Contact telephone number: | 01491 416381 | |
| Note: Annex should only be submitted to the FSA not the issuer | |
| Annex: Notification of major interests in share | |
| A: Identity of the persons or legal entity subject to the notification obligation | |
| Full name (including legal form of legal entities) |
|
| Contact address (registered office for legal entities) |
|
| Phone number & email | |
| Other useful information (at least legal representative for legal persons) |
|
| B: Identity of the notifier, if applicable | |
| Full name | Invesco Limited |
| Contact address | Registered address: 30 Finsbury Square, London. EC2A 1AG |
| Phone number & email | 020 7638 0731 |
| Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) |
|
| C: Additional information | |
| For notes on how to complete form TR-1 please see the FSA website. |
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLDMGMMDMFGFZM
More from Dechra Pharmaceuticals PLC
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Mar 9
Regulatory Filings
2025
Mar 3
Major Shareholding Notification
2024
Jan 23
Regulatory Filings
2024
Jan 18
Major Shareholding Notification
2024
Jan 18
Major Shareholding Notification
2024
Jan 17
Major Shareholding Notification
2024
Jan 17
Major Shareholding Notification
2024
Jan 17
Major Shareholding Notification
2024
Jan 17